S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules

Damage‐associated molecular pattern (DAMP) molecules have been introduced as important proinflammatory factors of innate immunity. One example known for many years to be expressed in cells of myeloid origin are phagocytic S100 proteins, which mediate inflammatory responses and recruit inflammatory cells to sites of tissue damage. An emerging concept of pattern recognition involves the multiligand receptor foradvanced glycation end products (RAGE) and Toll‐like receptors (TLRs) in sensing not only pathogen‐associated molecular patterns (PAMPs) but also endogenous DAMPs, including S100 proteins. S100A8, S100A9, and S100A12 are found at high concentrations in inflamed tissue, where neutrophils and monocytes belong to the most abundant cell types. They exhibit proinflammatory effects in vitro at concentrations found at sites of inflammation in vivo. Although S100A12 binds to RAGE, at least part of the proinflammatory effects of the S100A8/S100A9 complex depend upon interaction with other receptors. Because of the divergent expression patterns, the absence of S100A12 in rodents, the different interaction partners described, and the specific intracellular and extracellular effects reported for these proteins, it is important to differentiate between distinct S100 proteins rather than subsuming them with the term “S100/calgranulins.” Analyzing the molecular basis of the specific effects exhibited by these proteins in greater detail bears the potential to elucidate important mechanisms of innate immunity, to establish valid biomarkers of phagocytic inflammation, and eventually to reveal novel targets for innovative anti‐inflammatory therapies.

[1]  T. Vogl,et al.  Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. , 2006, Journal of molecular biology.

[2]  K. Gaus,et al.  S100A8 and S100A9 in Human Arterial Wall , 2005, Journal of Biological Chemistry.

[3]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[4]  D. Stern,et al.  Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.

[5]  J. Oppenheim,et al.  Alarmins: chemotactic activators of immune responses. , 2005, Current opinion in immunology.

[6]  K. Tracey,et al.  The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.

[7]  Jian Cai,et al.  Myeloid-Related Protein-14 Is a p38 MAPK Substrate in Human Neutrophils1 , 2005, The Journal of Immunology.

[8]  D. Foell,et al.  Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. , 2005, Blood.

[9]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[10]  D. Foell,et al.  Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis , 2005, Experimental dermatology.

[11]  I. Thorey,et al.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.

[12]  R. Donato,et al.  S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. , 2004, Biochimica et biophysica acta.

[13]  D. Foell,et al.  Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.

[14]  D. Foell,et al.  Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis , 2004, The Journal of pathology.

[15]  Y. Mori,et al.  Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[16]  C. Heizmann,et al.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). , 2004, Biochemical and biophysical research communications.

[17]  D. Foell,et al.  Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. , 2004, The American journal of cardiology.

[18]  K. Schroder,et al.  Probing the S100 protein family through genomic and functional analysis. , 2004, Genomics.

[19]  D. Foell,et al.  Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[20]  E. Schleicher,et al.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.

[21]  T. Hughes,et al.  Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products , 2004, Diabetologia.

[22]  D. Foell,et al.  Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. , 2004, Arthritis and rheumatism.

[23]  H. Huttunen,et al.  Amphoterin as an extracellular regulator of cell motility: from discovery to disease , 2004, Journal of internal medicine.

[24]  T. Hughes,et al.  Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. , 2004, Diabetes.

[25]  T. Vogl,et al.  Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis , 2004, Journal of leukocyte biology.

[26]  D. Foell,et al.  Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? , 2004, Annals of the rheumatic diseases.

[27]  W. Nacken,et al.  Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. , 2003, Trends in immunology.

[28]  O Fitzgerald,et al.  Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. , 2003, Rheumatology.

[29]  S. Verbeek,et al.  The Inhibitory Receptor FcγRII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of FcγRI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes , 2003 .

[30]  I. H. Engels,et al.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. , 2003, The American journal of pathology.

[31]  P. Rouleau,et al.  Blockade of S100A8 and S100A9 Suppresses Neutrophil Migration in Response to Lipopolysaccharide 1 , 2003, The Journal of Immunology.

[32]  D. Foell,et al.  Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[33]  J. Sixma,et al.  Thrombospondin‐1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  S. McColl,et al.  Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. , 2003, Arthritis and rheumatism.

[35]  D. Foell,et al.  Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease , 2003, Gut.

[36]  B. Bresnihan,et al.  Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. , 2003, Arthritis and rheumatism.

[37]  K. Wilson,et al.  Structure of the human S100A12-copper complex: implications for host-parasite defence. , 2003, Acta crystallographica. Section D, Biological crystallography.

[38]  D. Foell,et al.  S100A12 (EN-RAGE) in monitoring Kawasaki disease , 2003, The Lancet.

[39]  T. Vogl,et al.  Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. , 2003, Trends in immunology.

[40]  P. Rouleau,et al.  The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. , 2003, Clinical immunology.

[41]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[42]  M. Frosch,et al.  Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation , 2003, Annals of the rheumatic diseases.

[43]  X. Chen,et al.  Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system , 2003, Nature Medicine.

[44]  K. Nabbe,et al.  FcγRI Up-Regulation Induced by Local Adenoviral-Mediated Interferon-γ Production Aggravates Chondrocyte Death during Immune Complex-Mediated Arthritis , 2003 .

[45]  W. Nacken,et al.  Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro , 2003, Molecular and Cellular Biology.

[46]  A. Schmidt,et al.  Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. , 2002, Advanced drug delivery reviews.

[47]  B. Wolska-Kuśnierz,et al.  Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism , 2002, The Lancet.

[48]  C. Heizmann,et al.  S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.

[49]  P. Gregersen,et al.  RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response , 2002, Genes and Immunity.

[50]  N. Hogg,et al.  The S100 Family Heterodimer, MRP-8/14, Binds with High Affinity to Heparin and Heparan Sulfate Glycosaminoglycans on Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[51]  R. Jonsson,et al.  Leukocyte protein calprotectin and outcome in rheumatoid arthritis , 2002, Scandinavian journal of rheumatology.

[52]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[53]  I. Thorey,et al.  The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes* , 2001, The Journal of Biological Chemistry.

[54]  A. Waring,et al.  Calcitermin, a novel antimicrobial peptide isolated from human airway secretions , 2001, FEBS letters.

[55]  I. Bjarnason,et al.  Non-invasive investigation of inflammatory bowel disease. , 2001, World journal of gastroenterology.

[56]  M. Bachmann,et al.  On the Role of the Innate Immunity in Autoimmune Disease , 2001, The Journal of experimental medicine.

[57]  V. D’Agati,et al.  Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[58]  Tony S. Tao,et al.  Proinflammatory properties of the human S100 protein S100A12 , 2001, Journal of leukocyte biology.

[59]  A. Varki,et al.  Two Proteins Modulating Transendothelial Migration of Leukocytes Recognize Novel Carboxylated Glycans on Endothelial Cells1 , 2001, Journal of Immunology.

[60]  I. Bjarnason,et al.  Fecal calprotectin as an index of intestinal inflammation. , 2001, Drugs of today.

[61]  I. Chernushevich,et al.  Total chemical synthesis and chemotactic activity of human S100A12 (EN‐RAGE) , 2001, FEBS letters.

[62]  C. Sorg,et al.  Transendothelial migration of 27E10+ human monocytes. , 2000, International immunology.

[63]  M. Rastaldi,et al.  Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. , 2000, Journal of the American Society of Nephrology : JASN.

[64]  H. Rogniaux,et al.  Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis , 2000, Journal of the American Society for Mass Spectrometry.

[65]  N. Wulffraat,et al.  Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[66]  J. Garin,et al.  Calcium‐dependent secretion in human neutrophils: A proteomic approach , 2000, Electrophoresis.

[67]  M. Frosch,et al.  Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. , 1999, The Journal of rheumatology.

[68]  M. Hartmann,et al.  S100A12 Is Expressed Exclusively by Granulocytes and Acts Independently from MRP8 and MRP14* , 1999, The Journal of Biological Chemistry.

[69]  D. Hume,et al.  A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. , 1999, Journal of immunology.

[70]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[71]  M. Raftery,et al.  Oxidation Regulates the Inflammatory Properties of the Murine S100 Protein S100A8* , 1999, The Journal of Biological Chemistry.

[72]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[73]  W. Chazin,et al.  High Level Expression and Dimer Characterization of the S100 EF-hand Proteins, Migration Inhibitory Factor-related Proteins 8 and 14* , 1998, The Journal of Biological Chemistry.

[74]  N. Hogg,et al.  The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. , 1998, Journal of immunology.

[75]  P. Brandtzaeg,et al.  Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. , 1997, Gastroenterology.

[76]  M. Hartmann,et al.  Myeloid-related Protein (MRP) 8 and MRP14, Calcium-binding Proteins of the S100 Family, Are Secreted by Activated Monocytes via a Novel, Tubulin-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[77]  K. Schmid,et al.  The myeloic related protein MRP8/14 (27E10 antigen)— usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function , 1995, European journal of clinical investigation.

[78]  M. Goebeler,et al.  Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. , 1995, The Biochemical journal.

[79]  J. Brun,et al.  Effects of calprotectin in avridine‐induced arthritis , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[80]  E. Vollmer,et al.  Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. , 1994, Transplantation.

[81]  R. Jonsson,et al.  Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. , 1994, The Journal of rheumatology.

[82]  S. Wahl,et al.  Expression and cloning of migration inhibitory factor-related protein (MRP)8 and MRP14 in arthritis-susceptible rats. , 1993, Biochemical and biophysical research communications.

[83]  G. Hughes,et al.  Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity , 1993, Lupus.

[84]  M. Goebeler,et al.  Expression and complex assembly of calcium‐binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells , 1993, Journal of leukocyte biology.

[85]  B. Tümmler,et al.  Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. , 1992, Immunobiology.

[86]  M. Karas,et al.  Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. , 1991, The Journal of biological chemistry.

[87]  Y. Takasaki,et al.  Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. , 1990, Journal of biochemistry.

[88]  N. Hogg,et al.  lonomycin-regulated phosphorylation of the myeloid calcium-binding protein p14 , 1989, Nature.

[89]  M. Fagerhol,et al.  A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. , 1989, The Journal of rheumatology.

[90]  C. Sorg,et al.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. , 1988, Clinical and experimental immunology.

[91]  E. Lagasse,et al.  Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation , 1988, Molecular and cellular biology.

[92]  R. G. Clerc,et al.  Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis , 1987, Nature.

[93]  Veronica van Heyningen,et al.  A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene , 1987, Nature.

[94]  B. Moore A soluble protein characteristic of the nervous system. , 1965, Biochemical and biophysical research communications.

[95]  W. Nacken,et al.  Computational searches for missing orthologs: the case of S100A12 in mice. , 2004, Omics : a journal of integrative biology.

[96]  S. Verbeek,et al.  Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. , 2003, Arthritis and rheumatism.

[97]  K. Nabbe,et al.  FcgammaRI up-regulation induced by local adenoviral-mediated interferon-gamma production aggravates chondrocyte death during immune complex-mediated arthritis. , 2003, The American journal of pathology.

[98]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[99]  K. Schmid,et al.  Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. , 1995, Digestion.

[100]  E. Vollmer,et al.  MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. , 1993, Blood.

[101]  P. Mowinckel,et al.  The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. , 1991, The Journal of rheumatology.

[102]  M. Fagerhol,et al.  The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. , 1991, Scandinavian journal of rheumatology.

[103]  Aileen B. Sedman,et al.  A longitudinal study , 1987 .